Illumina Registers for $400M Resale of Convertible Notes | GenomeWeb
NEW YORK (GenomeWeb News) - Illumina said yesterday that it has filed a resale registration statement with the US Securities and Exchange Commission connected to the sale of $400 million worth of .625 percent convertible senior notes due 2014.
 
The notes were originally sold in February to institutional investors, and Illumina said at the time it planned to use $200 million of the proceeds to buy shares of its own stock in a private deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.